These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 18220081

  • 1. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group.
    Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
    [Abstract] [Full Text] [Related]

  • 2. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 3. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T, Krystal A, Steinberg FJ, Singh NN, Moline M.
    Sleep; 2013 Feb 01; 36(2):189-96. PubMed ID: 23372266
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 01; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
    Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T.
    Sleep; 2010 Nov 01; 33(11):1553-61. PubMed ID: 21102997
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK, Soubrane C, Roth T.
    Am J Geriatr Psychiatry; 2008 Jan 01; 16(1):44-57. PubMed ID: 18165461
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R, Murphy P, Zammit G, Mayleben D, Kumar D, Dhadda S, Filippov G, LoPresti A, Moline M.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1918254. PubMed ID: 31880796
    [Abstract] [Full Text] [Related]

  • 8. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.
    Fava M, Asnis GM, Shrivastava R, Lydiard B, Bastani B, Sheehan D, Roth T.
    J Clin Psychopharmacol; 2009 Jun 02; 29(3):222-30. PubMed ID: 19440075
    [Abstract] [Full Text] [Related]

  • 9. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC.
    Sleep; 2000 Dec 15; 23(8):1087-96. PubMed ID: 11145323
    [Abstract] [Full Text] [Related]

  • 10. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
    Erman MK, Zammit G, Rubens R, Schaefer K, Wessel T, Amato D, Caron J, Walsh JK.
    J Clin Sleep Med; 2008 Jun 15; 4(3):229-34. PubMed ID: 18595435
    [Abstract] [Full Text] [Related]

  • 11. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
    Roth T, Hull SG, Lankford DA, Rosenberg R, Scharf MB, Intermezzo Study Group.
    Sleep; 2008 Sep 15; 31(9):1277-84. PubMed ID: 18788653
    [Abstract] [Full Text] [Related]

  • 12. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 15; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 13. Zolpidem extended-release.
    Moen MD, Plosker GL.
    CNS Drugs; 2006 Oct 15; 20(5):419-26; discussion 427-8. PubMed ID: 16696581
    [Abstract] [Full Text] [Related]

  • 14. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB, Roth T, Vogel GW, Walsh JK.
    J Clin Psychiatry; 1994 May 15; 55(5):192-9. PubMed ID: 8071269
    [Abstract] [Full Text] [Related]

  • 15. Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study.
    Hajak G, Cluydts R, Declerck A, Estivill SE, Middleton A, Sonka K, Unden M.
    Int Clin Psychopharmacol; 2002 Jan 15; 17(1):9-17. PubMed ID: 11800507
    [Abstract] [Full Text] [Related]

  • 16. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
    Perlis ML, McCall WV, Krystal AD, Walsh JK.
    J Clin Psychiatry; 2004 Aug 15; 65(8):1128-37. PubMed ID: 15323600
    [Abstract] [Full Text] [Related]

  • 17. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
    Herrmann WM, Kubicki ST, Boden S, Eich FX, Attali P, Coquelin JP.
    J Int Med Res; 1993 Aug 15; 21(6):306-22. PubMed ID: 8143886
    [Abstract] [Full Text] [Related]

  • 18. Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study.
    Roehrs TA, Randall S, Harris E, Maan R, Roth T.
    Sleep; 2011 Feb 01; 34(2):207-12. PubMed ID: 21286241
    [Abstract] [Full Text] [Related]

  • 19. Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial.
    Dockhorn RJ, Dockhorn DW.
    Clin Neuropharmacol; 1996 Aug 01; 19(4):333-40. PubMed ID: 8828996
    [Abstract] [Full Text] [Related]

  • 20. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
    Roehrs TA, Roth T.
    J Clin Sleep Med; 2016 Mar 01; 12(3):319-25. PubMed ID: 26446253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.